830 related articles for article (PubMed ID: 33944541)
21. Antibiotic desensitization in adults with cystic fibrosis.
Burrows JA; Toon M; Bell SC
Respirology; 2003 Sep; 8(3):359-64. PubMed ID: 12911831
[TBL] [Abstract][Full Text] [Related]
22. Risk stratification and skin testing to guide re-exposure in taxane-induced hypersensitivity reactions.
Picard M; Pur L; Caiado J; Giavina-Bianchi P; Galvão VR; Berlin ST; Campos SM; Matulonis UA; Castells MC
J Allergy Clin Immunol; 2016 Apr; 137(4):1154-1164.e12. PubMed ID: 26725998
[TBL] [Abstract][Full Text] [Related]
23. Platinum Chemotherapy Hypersensitivity: Prevalence and Management.
Otani IM; Wong J; Banerji A
Immunol Allergy Clin North Am; 2017 Nov; 37(4):663-677. PubMed ID: 28965633
[TBL] [Abstract][Full Text] [Related]
24. Retrospective evaluation of a rechallenge protocol in patients experiencing hypersensitivity reactions with prior chemotherapy in a tertiary hospital.
Wu HL
J Oncol Pharm Pract; 2019 Sep; 25(6):1388-1395. PubMed ID: 30176784
[TBL] [Abstract][Full Text] [Related]
25. Oxaliplatin-induced hypersensitivity reactions: risk factors and management.
Selcuk A; Yıldız B
Eur Rev Med Pharmacol Sci; 2023 Mar; 27(6):2640-2645. PubMed ID: 37013782
[TBL] [Abstract][Full Text] [Related]
26. Rapid Drug Desensitization with Biologics: A Single-Center Experience with Four Biologics.
Bavbek S; Kendirlinan R; Çerçi P; Altıner S; Soyyiğit Ş; Çelebi Sözener Z; Aydın Ö; Gümüşburun R
Int Arch Allergy Immunol; 2016; 171(3-4):227-233. PubMed ID: 28049204
[TBL] [Abstract][Full Text] [Related]
27. Clopidogrel hypersensitivity: a novel multi-day outpatient oral desensitization regimen.
Fajt M; Petrov A
Ann Pharmacother; 2010 Jan; 44(1):11-8. PubMed ID: 20009004
[TBL] [Abstract][Full Text] [Related]
28. Platin desensitizations in thoracic malignancies and risk factors for breakthrough reactions.
Buhari GK; Kalkan İK; Ateş H; Bahçecioğlu SN; Demir Ş; Yeşilkaya S; Solak GTV; Aksu K; Erkekol FÖ
Allergol Immunopathol (Madr); 2023; 51(2):130-136. PubMed ID: 36916098
[TBL] [Abstract][Full Text] [Related]
29. Breakthrough reactions during rapid drug desensitization: Clinical outcome and risk factors.
Kang Y; Kwon OY; Jung H; Kang M; An J; Lee JH; Won HK; Song WJ; Kwon HS; Cho YS; Moon HB; Kim TB
Ann Allergy Asthma Immunol; 2019 Jul; 123(1):48-56.e1. PubMed ID: 31108181
[TBL] [Abstract][Full Text] [Related]
30. Methotrexate hypersensitivity reactions in pediatrics: Evaluation and management.
Dilley MA; Lee JP; Broyles AD
Pediatr Blood Cancer; 2017 May; 64(5):. PubMed ID: 27786403
[TBL] [Abstract][Full Text] [Related]
31. Key elements in hypersensitivity reactions to chemotherapy: experience with rapid drug desensitization in gynaecological cancer in a Tertiary Hospital.
Alen Coutinho I; Costa Sousa F; Cunha F; Frutuoso C; Ribeiro C; Loureiro C; Águas F; Todo Bom A
Eur Ann Allergy Clin Immunol; 2022 Nov; 54(6):265-276. PubMed ID: 33944544
[TBL] [Abstract][Full Text] [Related]
32. Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment.
Brennan PJ; Rodriguez Bouza T; Hsu FI; Sloane DE; Castells MC
J Allergy Clin Immunol; 2009 Dec; 124(6):1259-66. PubMed ID: 19910036
[TBL] [Abstract][Full Text] [Related]
33. Usefulness of Omalizumab in Rapid Drug Desensitization in Patients With Severe Anaphylaxis Induced by Carboplatin: Open Questions.
Sánchez-Morillas L; Casado Herráez A; Rubio-Perez M; Robledo Echarren T; González Gutiérrez ML; Cimarra M; Vázquez Cortés S; Cerecedo I; Fernández-Rivas M
J Investig Allergol Clin Immunol; 2020; 30(4):298-300. PubMed ID: 32101175
[No Abstract] [Full Text] [Related]
34. Delving into cornerstones of hypersensitivity to antineoplastic and biological agents: value of diagnostic tools prior to desensitization.
Alvarez-Cuesta E; Madrigal-Burgaleta R; Angel-Pereira D; Ureña-Tavera A; Zamora-Verduga M; Lopez-Gonzalez P; Berges-Gimeno MP
Allergy; 2015 Jul; 70(7):784-94. PubMed ID: 25832325
[TBL] [Abstract][Full Text] [Related]
35. Low Cross-Reactivity Between Cisplatin and Other Platinum Salts.
Pasteur J; Favier L; Pernot C; Guerriaud M; Bernigaud C; Lepage C; Jouve JL; Isambert N; Collet E
J Allergy Clin Immunol Pract; 2019; 7(6):1894-1900. PubMed ID: 30776524
[TBL] [Abstract][Full Text] [Related]
36. Successful desensitization protocol for hypersensitivity reactions caused by oxaliplatin.
Rosique-Robles D; Vicent Verge JM; Borrás-Blasco J; Giner-Marco V; Casterá E; Galan-Brotons A; Abad J
Int J Clin Pharmacol Ther; 2007 Nov; 45(11):606-10. PubMed ID: 18077926
[TBL] [Abstract][Full Text] [Related]
37. A new rapid desensitization protocol for chemotherapy agents.
Gastaminza G; de la Borbolla JM; Goikoetxea MJ; Escudero R; Antón J; Espinós J; Lacasa C; Fernández-Benítez M; Sanz ML; Ferrer M
J Investig Allergol Clin Immunol; 2011; 21(2):108-12. PubMed ID: 21462800
[TBL] [Abstract][Full Text] [Related]
38. Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell/IgE-mediated reactions.
Lee CW; Matulonis UA; Castells MC
Gynecol Oncol; 2004 Nov; 95(2):370-6. PubMed ID: 15491759
[TBL] [Abstract][Full Text] [Related]
39. Rapid desensitization for hypersensitivity reactions to paclitaxel and docetaxel: a new standard protocol used in 77 successful treatments.
Feldweg AM; Lee CW; Matulonis UA; Castells M
Gynecol Oncol; 2005 Mar; 96(3):824-9. PubMed ID: 15721432
[TBL] [Abstract][Full Text] [Related]
40. Desensitization in delayed drug hypersensitivity reactions -- an EAACI position paper of the Drug Allergy Interest Group.
Scherer K; Brockow K; Aberer W; Gooi JH; Demoly P; Romano A; Schnyder B; Whitaker P; Cernadas JS; Bircher AJ;
Allergy; 2013 Jul; 68(7):844-52. PubMed ID: 23745779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
